Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Guided Therapeutics Inc (GTHP)
OTHER OTC:GTHP
Holding GTHP?
Track your performance easily
GTHP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.06 - $0.25
Previous Close$0.16
Volume6.50K
Average Volume (3M)13.31K
Market Cap
$9.05M
Enterprise Value$11.19M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$2.14M
Price to Earnings (P/E)―
Beta0.95
Next Earnings
Nov 13, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding56,550,370
10 Day Avg. Volume40,661
30 Day Avg. Volume13,314
Standard Deviation0.30
R-Squared0.00751
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)-2.00
Price to Sales (P/S)238.09
Price to Cash Flow (P/CF)-10.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue136.45
Enterprise Value/Gross Profit310.79
Enterprise Value/Ebitda-4.33
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
GTHP FAQ
What was Guided Therapeutics Inc’s price range in the past 12 months?
Guided Therapeutics Inc lowest stock price was $0.06 and its highest was $0.25 in the past 12 months.
What is Guided Therapeutics Inc’s market cap?
Currently, no data Available
When is Guided Therapeutics Inc’s upcoming earnings report date?
Guided Therapeutics Inc’s upcoming earnings report date is Nov 13, 2023 which is 358 days ago.
How were Guided Therapeutics Inc’s earnings last quarter?
Guided Therapeutics Inc released its earnings results on Aug 15, 2023. The company reported -$0.032 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.032.
Is Guided Therapeutics Inc overvalued?
According to Wall Street analysts Guided Therapeutics Inc’s price is currently Overvalued.
Does Guided Therapeutics Inc pay dividends?
Guided Therapeutics Inc does not currently pay dividends.
What is Guided Therapeutics Inc’s EPS estimate?
Guided Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Guided Therapeutics Inc have?
Guided Therapeutics Inc has 56,550,370 shares outstanding.
What happened to Guided Therapeutics Inc’s price movement after its last earnings report?
Guided Therapeutics Inc reported an EPS of -$0.032 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Guided Therapeutics Inc?
Currently, no hedge funds are holding shares in GTHP
---
Guided Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.92%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-46.72%
Trailing 12-Months
Company Description
Guided Therapeutics Inc
Guided Therapeutics, Inc. enagges in the development of medical devices. It focuses on the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. The company was founded by Shabbir Bakir Bambot, Mark L. Faupel, and Richard L. Fowler on October 27, 1992 and is headquartered in Norcross, GA.
---
Technical Analysis
---